3/13
11:11 pm
iova
Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]
3/8
10:34 pm
iova
Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]
Medium
Report
Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]
3/7
08:17 pm
iova
Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]
Medium
Report
Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]
3/7
01:38 am
iova
Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]
Medium
Report
Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]
3/6
12:18 pm
iova
UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]
Low
Report
UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]
3/5
05:55 pm
iova
Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]
High
Report
Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]
3/5
10:24 am
iova
Iovance Biotherapeutics (IOVA) had its price target raised by UBS Group AG from $2.00 to $4.00. They now have a "neutral" rating on the stock.
High
Report
Iovance Biotherapeutics (IOVA) had its price target raised by UBS Group AG from $2.00 to $4.00. They now have a "neutral" rating on the stock.
3/3
08:50 am
iova
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "market outperform". They now have a $5.00 price target on the stock.
Low
Report
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "market outperform". They now have a $5.00 price target on the stock.
2/27
07:35 pm
iova
Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success [Yahoo! Finance]
2/27
04:21 pm
iova
Is Iovance Biotherapeutics (IOVA) Pricing Reflect Recent Cell Therapy Progress Accurately [Yahoo! Finance]
Low
Report
Is Iovance Biotherapeutics (IOVA) Pricing Reflect Recent Cell Therapy Progress Accurately [Yahoo! Finance]
2/26
08:00 am
iova
Iovance Biotherapeutics to Present at Upcoming Conferences
Low
Report
Iovance Biotherapeutics to Present at Upcoming Conferences
2/25
10:58 am
iova
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
High
Report
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
2/25
09:24 am
iova
Iovance Biotherapeutics (IOVA) had its price target lowered by Chardan Capital from $17.00 to $16.00. They now have a "buy" rating on the stock.
Medium
Report
Iovance Biotherapeutics (IOVA) had its price target lowered by Chardan Capital from $17.00 to $16.00. They now have a "buy" rating on the stock.
2/25
08:12 am
iova
Iovance Biotherapeutics Inc (IOVA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics Inc (IOVA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
2/25
08:00 am
iova
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "outperform". They now have a $5.00 price target on the stock.
Low
Report
Iovance Biotherapeutics (IOVA) was upgraded by Citizens Jmp from "market perform" to "outperform". They now have a $5.00 price target on the stock.
2/24
04:53 pm
iova
Iovance Biotherapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/24
03:51 pm
iova
Iovance Biotherapeutics: Better Gross Margin And Faster Turnaround Support A Higher Floor (Rating Upgrade) [Seeking Alpha]
Neutral
Report
Iovance Biotherapeutics: Better Gross Margin And Faster Turnaround Support A Higher Floor (Rating Upgrade) [Seeking Alpha]
2/24
01:06 pm
iova
Iovance Biotherapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
09:32 am
iova
Iovance Biotherapeutics Says Potential Sarcoma Therapy Shows 50% Response Rate in Pilot Clinical Trial [Yahoo! Finance]
High
Report
Iovance Biotherapeutics Says Potential Sarcoma Therapy Shows 50% Response Rate in Pilot Clinical Trial [Yahoo! Finance]
2/24
07:36 am
iova
Iovance Biotherapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Iovance Biotherapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
2/24
07:00 am
iova
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
High
Report
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
2/24
07:00 am
iova
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
High
Report
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
2/20
05:15 pm
iova
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2/19
10:09 am
iova
Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds? [Yahoo! Finance]
Medium
Report
Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds? [Yahoo! Finance]
2/17
09:02 pm
iova
Iovance Biotherapeutics Inc. (IOVA) Builds Momentum With New Trial Data [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics Inc. (IOVA) Builds Momentum With New Trial Data [Yahoo! Finance]